PacBridge Capital Partners (HK) Limited, a Hong Kong-based investment firm, has committed to a C$12 million ($9.46 million) facility to fund Contextual Genomics Inc., a Canadian cancer genomics company.
Sue Paish, former President and CEO of LifeLabs Medical Laboratory Services, and James Lumsdaine of PacBridge will join the Contextual Genomics’ Board of Directors, post investment.
